Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney
January 8th, 2018
18.8K views
This protocol describes a method to inject plasmid DNA into the mouse kidney via the renal pelvis to produce transgene expression specifically in the kidney.
Overview
This protocol describes a method to inject plasmid DNA into the mouse kidney via the renal pelvis to produce transgene expression specifically in the kidney. This technique allows for reproducible protein expression in the adult mouse kidney, addressing key questions in nephrology.
Key Study Components
Area of Science
- Nephrology
- Gene Therapy
- Molecular Biology
Background
- Understanding protein expression in the kidney is crucial for nephrology research.
- Existing methods may lead to gene expression in multiple organs.
- This technique focuses on specific expression in the kidney.
- Visual demonstration is essential for successful execution of the method.
Purpose of Study
- To produce protein expression from plasmid DNA in the adult mouse kidney.
- To investigate the effects of specific proteins on kidney function.
- To provide a reliable method for nephrology research.
Methods Used
- Resuspension of plasmid DNA in hydrodynamic delivery buffer.
- Placement of the mouse on a water circulated heat pad.
- Injection of plasmid DNA into the renal pelvis.
- Careful exposure and quick execution of the injection.
Main Results
- Successful transgene expression in the kidney.
- Reproducibility of protein expression demonstrated.
- Specific targeting of the kidney achieved.
- Method validated for further nephrology studies.
Conclusions
- This method provides a new tool for nephrology research.
- It allows for targeted gene expression in the kidney.
- Visual guidance enhances the success of the procedure.
Frequently Asked Questions
What is the main advantage of this injection method?
The main advantage is that it produces protein expression specifically in the kidney, avoiding expression in other organs.
Why is visual demonstration important?
Visual demonstration is critical as the injection requires careful exposure and must be done quickly for effective DNA entry into cells.
What is the purpose of resuspending plasmid DNA?
Resuspending plasmid DNA in hydrodynamic delivery buffer prepares it for injection into the renal pelvis.
How does this method contribute to nephrology research?
It allows researchers to study the effects of specific proteins on kidney function in a controlled manner.
What type of animal is used in this protocol?
The protocol uses adult mice for the injection of plasmid DNA.
Is this method reproducible?
Yes, the method has been shown to produce reproducible results in protein expression.
Executive Industry Relevance
This method enables kidney-specific protein expression in adult mice, addressing a critical gap in nephrology research where systemic delivery often leads to off-target effects. By providing reproducible, localized transgene expression, it supports mechanistic de-risking of renal targets and pathway validation. The technique enhances predictive confidence in early discovery by isolating kidney-specific biological responses.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses in a kidney-specific context without confounding organ-wide expression.
- Operational Value: Provides reproducible protein expression in the adult mouse kidney, supporting consistent target validation experiments.
- Predictive Value: Facilitates biological de-risking by isolating renal phenotypes and reducing mechanistic ambiguity in nephrology target assessment.
Screening & Assay Development
- Assay Readiness: Generates quantifiable outputs via luciferase or fluorescent reporters for downstream screening validation.
- Reproducibility: Delivers consistent transfection efficiency across animals, enabling reliable compound or modulator screening in kidney disease models.
- Platform Utility: Supports development of kidney-specific assays that can be reused across target validation campaigns.
Translational & Preclinical Research
- Disease Relevance: Models human kidney pathophysiology by enabling targeted expression of disease-associated proteins in renal tissue.
- Translational Continuity: Bridges discovery to preclinical validation by providing a reproducible system for protein function studies in the kidney.
- Risk-Adjusted Advancement: Informs go/no-go decisions by clarifying renal-specific target effects prior to broader phenotypic screening.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target hypothesis testing to preclinical validation, specifically enabling kidney-focused mechanistic studies before lead identification.
- Discovery Biology: Supports hypothesis testing and pathway clarification by restricting protein expression to the kidney, reducing systemic confounders.
- Screening: Enables assay standardization through reproducible reporter expression, facilitating quantitative evaluation of renal targets.
- Analytics: Provides measurable outputs such as bioluminescence and fluorescence for comparing expression levels across conditions.
- Translational Research: Connects to preclinical work by validating renal-specific protein effects in a physiologically relevant model.
- Enterprise Reuse: Establishes a reusable surgical platform for multiple nephrology targets, reducing redundant model development.
Operational & Enterprise Impact
- Scientific Value: Increases target validation confidence by eliminating off-target expression artifacts in renal studies.
- Operational Value: Standardizes delivery to the renal pelvis, improving reproducibility across laboratories and experimental batches.
- Strategic Value: Enhances capital efficiency by reducing failed studies due to nonspecific expression, streamlining nephrology target triage.
- Portfolio Impact: Supports risk-adjusted prioritization of renal targets through clearer mechanistic insights from kidney-specific expression data.
Implementation Considerations
- Requires microsurgical expertise for renal pelvis exposure and cannulation under anesthesia.
- Depends on sterile surgical instrumentation, hydrodynamic delivery buffer preparation, and imaging systems for transfection assessment.
- Necessitates cross-team standardization between surgery, imaging, and molecular biology teams for consistent execution.
- Adaptation considerations include variations in kidney size, fibrosis status, and age, with best results in young, non-fibrotic mice.
- Practical limitations include lower transfection efficiency in older or diseased kidneys and the need for rapid injection to prevent backflow.
Biopharma FAQs
Why does renal pelvis injection improve target validation in nephrology?
It enables kidney-specific protein expression without systemic off-target effects, allowing researchers to isolate renal phenotypes and clarify target mechanisms with greater confidence.
How does rapid injection into the renal pelvis support reproducible transgene expression?
The fast delivery creates hydrodynamic pressure that facilitates plasmid entry into renal cells, and maintaining needle placement for 10 seconds prevents backflow, ensuring consistent transfection efficiency.
What quantitative measurements enable assessment of transfection efficiency in this method?
Live animal imaging using luciferase-expressing plasmids, Western blot, and immunohistochemistry provide quantifiable readouts of gene expression levels in the kidney.
Why are replication requirements important for cross-functional collaboration in this procedure?
Reproducible results across animals and experiments allow surgery, imaging, and molecular biology teams to rely on consistent data for target assessment and decision-making.
What statistical analysis capabilities are required before implementing this method in a discovery pipeline?
Teams must be able to quantify and compare expression levels across conditions using imaging or biochemical assays to evaluate target effects with sufficient statistical power.
